Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
24,164
Total Claims
$759K
Drug Cost
324
Beneficiaries
$2,342
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+66%
Cost per patient vs peers
$2,342 vs $1,411 avg
-14%
Brand preference vs peers
9.1% vs 10.6% avg
Brand vs Generic
Brand: 2,196 claims · $480K
Generic: 21,845 claims · $268K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 672 | $103K |
| Dulaglutide | 25 | $23K |
| Rivaroxaban | 112 | $23K |
| Mirabegron | 159 | $18K |
| Empagliflozin | 102 | $15K |
| Atorvastatin Calcium | 1,703 | $13K |
| Insulin Aspart | 42 | $12K |
| Liraglutide | 20 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $11K |
| Pen Needle,dual Safety,diabetc | 107 | $10K |
| Linagliptin | 77 | $10K |
| Insulin Detemir | 30 | $9,874 |
| Budesonide/Formoterol Fumarate | 24 | $9,738 |
| Insulin Glargine,hum.Rec.Anlog | 30 | $9,238 |
| Aripiprazole | 138 | $9,085 |
Prescribing Profile
Patient Profile
74
Avg Age
53%
Female
1.89
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data